Berkshire Hathaway: Abel's Capital Deployment Shift Is Real, but the Stock Has Run to Fair Value — Hold

Berkshire Hathaway's Q2 earnings, reported today, confirm what had been visible for months: Greg Abel is deploying capital in ways Warren Buffett rarely did in his later years. The cash pile is declining, buybacks are accelerating, the company is back as a net buyer of equities, and a $6.8 billion acquisition has closed. That is the right direction.

But the stock has already run. BRK-B closed at $521.80 on Friday, near its 52-week high of $525.44, trading at roughly 1.43 times book value — well above the historical zone where Buffett himself felt comfortable buying back shares. The capital deployment shift is real. The upside at this price, however, is not where it used to be. I rate the stock a Hold.

What actually changed

Operating earnings rose 16% to $12.98 billion in Q2, up from $11.16 billion a year earlier. Manufacturing, service, and retailing jumped 24% to $4.47 billion. Berkshire Hathaway Energy surged 27% to $891 million. BNSF added 6% to $1.56 billion. Insurance underwriting earnings were the weak link, down 13% to $1.73 billion, and insurance investment income fell 9% to $3.06 billion — reflecting lower yields on the shrinking cash hoard and a reduced portfolio.

Total profit more than doubled to $25.67 billion, but that figure is dominated by one-time investment gains and swings in the portfolio. Operating earnings are the better measure of the underlying business, and the 16% growth there is solid without being extraordinary.

The story investors care about isn't the earnings print. It's the cash.

The cash pile is finally moving

At the end of June, Berkshire's cash and short-term investments stood at $365.5 billion, down from a record $397.4 billion at the end of March. This is the first decline in the cash pile in more than three years — the first reversal after 14 consecutive quarters of accumulation.

The $32 billion reduction in one quarter is a concrete signal of intent. Buybacks accelerated sharply: $4.5 billion repurchased in Q2 versus $235 million in Q1. More striking, Berkshire became a net buyer of equities for the first time in five years, with nearly $20 billion in net stock purchases. That ended a 14-quarter streak of net selling.

Under Buffett's late tenure, the absence of attractive deals at the right price meant sitting on cash. Abel is not sitting. He announced the resumption of the buyback program in March, and Q2 was the first quarter where the pace reflected serious deployment.

Acquisitions and portfolio choices

The Taylor Morrison acquisition closed July 24. Berkshire paid $72.50 per share in cash for the homebuilder, valuing the company at roughly $6.8 billion in equity and $8.5 billion in enterprise value — a 24% premium to pre-announcement pricing. Taylor Morrison is being integrated into Clayton Properties Group, alongside Berkshire's existing collection of 15 regional and local homebuilders. The deal extends Berkshire's footprint across the entire building economy: homebuilding, materials (Acme Brick, Johns Manville, Benjamin Moore, MiTek), flooring (Shaw Industries), mortgage finance, and brokerage.

Abel also oversaw a $10 billion investment in Alphabet through a private placement of Class A and Class C shares at roughly a 5-6% discount to market. Alphabet is now Berkshire's seventh-largest position by value, at over $16.6 billion, and is among the top five holdings alongside Apple, American Express, Bank of America, and Coca-Cola. This is the kind of tech and AI-adjacent exposure Buffett historically avoided — Abel is not.

The portfolio itself has been condensed. Q1 filings showed just 29 public positions, down from 42 a year earlier, with 91% of assets concentrated in the top ten holdings. Berkshire eliminated positions in Visa, Mastercard, UnitedHealth, and Amazon, while adding Delta Air Lines ($2.6 billion) and Macy's ($55 million). The Japanese trading house stakes, worth more than $35 billion, are now treated as comparable to major U.S. holdings in importance.

The shift from scattered diversification to concentrated conviction is intentional. Abel wants fewer, higher-quality bets rather than a broad portfolio of modest positions.

Valuation: the problem today

Here is where the upgrade narrative runs into the numbers.

BRK-B trades at roughly 14.3 times trailing earnings and 1.43 times book value. The P/E has declined from 16.2x at the end of 2025, which is a modest reset — not the kind of valuation compression that creates compelling upside. The stock has gained 9% over the last three months heading into this earnings report, while the S&P 500 gained 13% year-to-date. Berkshire is up just 3% on the year.

Buffett historically bought back Berkshire shares only when the market price traded below conservative estimates of intrinsic value — typically below 1.2x book, and he preferred to buy when the market was in distress. At 1.43x book, the stock is not cheap by Berkshire's own historical standards. Abel has told CNBC he continues the longstanding policy of buying back shares only when intrinsic value exceeds market price, but the fact that $4.5 billion in buybacks was executed at current levels suggests his valuation bar is less conservative than Buffett's.

The broader context matters. Morningstar estimated a fair value of $510 per share back in March 2026. The current price of $521.80 sits at or above that estimate. One Reddit-based intrinsic value model from July placed fair value between $404 and $485, with book value per share at roughly $337. The stock has run well ahead of book value growth.

The case for the upgrade thesis — and why it hasn't caught up

The bull case runs like this: Abel is deploying capital, the cash pile is shrinking, buybacks are accelerating, and the operating businesses are growing at a mid-teens clip. The Taylor Morrison deal positions Berkshire for the housing recovery, the Alphabet bet gives it AI exposure, and the condensed portfolio means higher conviction in each holding. The valuation looks reasonable for a diversified holding company that generates $50+ billion in annual operating earnings.

That's directionally right. But the stock has already absorbed a fair amount of this optimism. The 9% rally into earnings, the trade near 52-week highs, and the 1.43x book multiple suggest the market is pricing in a smoother Abel transition than the evidence demands. One quarter of accelerated buybacks does not rewrite the long-term compounding math. The $20 billion in net equity purchases is a step, but Berkshire still holds $365.5 billion in cash — the deployment rate would need to stay elevated for multiple quarters before the multiple itself expands meaningfully.

Risks

Three risks sit below the surface:

• Insurance weakness: Underwriting earnings fell 13% and investment income declined 9%. Insurance is Berkshire's profit engine and its source of cheap capital via the float. A softening in this segment could slow the overall earnings growth rate and reduce the internal capital available for acquisitions and buybacks.
• Housing timing: The Taylor Morrison deal bets on a housing recovery that may still be months away. Elevated mortgage rates and high prices have kept first-time buyer activity suppressed. If affordability does not improve in 2026-2027, the integration economics with Clayton Homes become a bridge, not a catalyst.
• Valuation discipline: Abel's willingness to buy back shares at 1.43x book and invest $10 billion in a single tech name signals a less patient approach than Buffett's. That could mean faster deployment and better returns — or it could mean the company pays up during periods of market euphoria and earns lower risk-adjusted returns on the deployed capital.

The rating

Hold. The capital deployment shift under Abel is genuine, and the direction is correct. The cash pile is moving, buybacks are scaling, and the portfolio is being rebuilt with higher conviction. But BRK-B at $522, trading near its 52-week high and at 1.43x book, does not offer the margin of safety this stock needs to justify new money. Buffett's own valuation discipline would have waited for a deeper reset.

The case becomes a Buy if the stock falls to the $450-$470 range — roughly 1.15-1.25x book, where the valuation gap between price and intrinsic value would be wide enough to absorb execution risk. A trigger in the other direction would be two consecutive quarters of operating earnings growth below 10% combined with insurance underwriting continuing to deteriorate. That would suggest the operating engine is slowing faster than the multiple can contract.

Until then, the shift is real but the price is fair. Investors who already own BRK-B can hold with confidence. New money waits.